Skip to main content
main-content

Type 1 diabetes

medwireNews top story

Real-world data support early insulin pump initiation in children

Child with insulin pump

Starting children on an insulin pump within 6 months of type 1 diabetes diagnosis is associated with improved outcomes relative to delaying for 2 or 3 years, shows an analysis of data from the DPV registry.

medwireNews top story

Life quality remains high after many decades with type 1 diabetes

Motorhome on the open road

Many people still have an excellent quality of life after 40 or 50 years of living with type 1 diabetes, show findings from the French JUBILE study.

medwireNews top story

Closed-loop system shows promise for people with unstable type 1 diabetes

Artificial pancreas concept

A closed-loop insulin delivery system may offer significantly better glycemic control than an open-loop system with predictive low glucose suspend in islet transplant candidates with highly unstable type 1 diabetes, research shows.

medwireNews top story

CGM data followers can give life quality boost

Friends having a good time over coffee

Sharing continuous glucose monitoring data with a chief follower has multiple quality of life and health benefits for people with type 1 diabetes, a study shows.

medwireNews top story

Excess mortality problem is not shrinking in young people with type 1 diabetes

Angel headstone

Absolute mortality rates are falling among younger people with type 1 diabetes, but excess mortality relative to the general population remains high and unchanged, show Scottish national registry data presented at the virtual 56th EASD Annual Meeting.

EASD 2020

COVID-19 and diabetes: The current evidence

Juliana Chan

Juliana Chan outlines current knowledge about the relationship between diabetes and COVID-19, discussing risk factors for poor outcomes in people with both conditions and the need for collaborative efforts to improve patient care (7:09).

medwireNews top story

Type 1, type 2 diabetes linked to elevated COVID-19 mortality risk

Doctor checking on Covid-19 infected patient connected to a ventilator

Both type 1 and type 2 diabetes are independently associated with an increased risk for death among hospitalized patients with COVID-19, and a number of factors including poor glycemic control and BMI may predict mortality risk, suggest findings from two studies published in The Lancet Diabetes & Endocrinology.

medwireNews top story

Dual targets difficult to reach in type 1 diabetes

Female archer aiming at target

People with type 1 diabetes treated with multiple daily insulin injections struggle to achieve guideline-recommended targets for time in hypoglycemia while simultaneously reaching their glycated hemoglobin goals, researchers report.

Featured podcast episode

Expert commentary: Closed-loop insulin delivery research update

Rayhan Lal / concept image of pancreas

Engineer turned endocrinologist Rayhan Lal reflects on the shape of artificial pancreas research and what changes are needed to best benefit people with diabetes (18:54).

medwireNews top story

Variable CGM benefits in high-risk subgroups

CGM

Continuous glucose monitoring is well accepted and reduces time in hypoglycemia among older individuals with type 1 diabetes, report researchers in JAMA.

01-12-2021 | Adolescents | News

Obesity flags high-risk cardiorenal profile in youth with type 1 diabetes

Adolescents with type 1 diabetes who are obese have a cardiorenal risk profile similar to that of their peers with type 2 diabetes, say researchers.

01-08-2021 | Ketoacidosis | News

DKA predictors could facilitate targeted SGLT2 inhibitor use in type 1 diabetes

Increased BMI and insulin resistance are important predictors of diabetic ketoacidosis risk among people with type 1 diabetes using SGLT2 inhibitors, say the authors of a meta-analysis and meta-regression.

01-07-2021 | Hypoglycemia | News

Any residual C-peptide offers protection for people with type 1 diabetes

Any amount of residual C-peptide is protective against some type 1 diabetes complications, show findings from a large, population-based study.

01-06-2021 | Continuous glucose monitoring | News

Trial demonstrates some benefits of CGM in young children with type 1 diabetes

The use of continuous glucose monitoring does not increase time in range in young children with type 1 diabetes, but may improve other glycemic indices, researchers report.

01-04-2021 | COVID-19 | News

COVID-19 risk not equal among people with diabetes

The risk for fatal or critical care unit-treated COVID-19 varies among people with diabetes and can be reasonably well predicted by their clinical history, UK study findings indicate.

12-16-2020 | Aflibercept | News

Similar visual outcomes may be achieved with aflibercept vs vitrectomy

Intravitreous aflibercept and vitrectomy with panretinal laser photocoagulation appear to have similar efficacy over 24 weeks when used for the treatment of vitreous hemorrhage from proliferative diabetic retinopathy, researchers report.

12-11-2020 | Ethnic groups | News

Racial minorities have reduced likelihood of receiving diabetes technologies

US researchers have identified racial disparities in the receipt of diabetes technologies among young adults with type 1 diabetes.

12-10-2020 | Children | News

DKA linked to concurrent kidney, brain injury in children

Acute kidney injury is common in children with diabetic ketoacidosis and is associated with circulatory volume depletion, greater acidosis, and signs of cerebral injury, US study data show.

12-07-2020 | Diabetes distress | News

Emotional regulation ‘meaningfully linked’ to diabetes distress

Negative emotional experience and skill at regulating emotions are associated with diabetes distress in adults with type 1 or type 2 diabetes, researchers report.

12-02-2020 | Insulin pumps | News

Real-world data support early insulin pump initiation in children

Starting children on an insulin pump within 6 months of type 1 diabetes diagnosis is associated with improved outcomes relative to delaying for 2 or 3 years, shows an analysis of data from the DPV registry.

12-01-2020 | Faster-acting insulin aspart | News

Real-world data support improved glycemic control with faster aspart

Switching to fast-acting insulin aspart significantly improves glycemic control and time in glucose target range in people with type 1 diabetes using continuous glucose monitoring, data from the real-world GoBolus study show.

11-20-2020 | Quality of life | News

Life quality remains high after many decades with type 1 diabetes

Many people still have an excellent quality of life after 40 or 50 years of living with type 1 diabetes, show findings from the French JUBILE study.

11-13-2020 | Disordered eating | News

Very high blood glucose may hint at disordered eating in type 1 diabetes

Women with type 1 diabetes and a history of disordered eating spend markedly more time in level 2 hyperglycemia than women without eating disorders, show the results of a small continuous glucose monitoring study.

11-09-2020 | Continuous glucose monitoring | News

Children persist best with CGM if started concurrently with insulin pump

Children with type 1 diabetes make more consistent use of continuous glucose monitoring if they are given the device when they initiate insulin pump therapy, rather than several months later, show the CGM TIME Trial results.

Image Credits